Hemodynamic Effects of Sacubitril-Valsartan in Heart Failure with Reduced-Ejection Fraction: Are All Doses Created Equal?

被引:0
|
作者
Masetti, M. [1 ]
Corazza, F. [1 ]
Giovannini, L. [1 ]
Russo, A. [1 ]
Prestinenzi, P. [1 ]
Boschi, S. [1 ]
Potena, L. [1 ]
机构
[1] Univ Bologna, Cardiovasc Dept, Bologna, Italy
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
108
引用
收藏
页码:S53 / S53
页数:1
相关论文
共 50 条
  • [31] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
  • [32] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    Paul L. McCormack
    Drugs, 2016, 76 : 387 - 396
  • [33] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    McCormack, Paul L.
    DRUGS, 2016, 76 (03) : 387 - 396
  • [34] Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
    Pascual-Figal, Domingo
    Bayes-Genis, Antoni
    Beltran-Troncoso, Paola
    Caravaca-Perez, Pedro
    Conde-Martel, Alicia
    Crespo-Leiro, Maria G.
    Delgado, Juan F.
    Diez, Javier
    Formiga, Francesc
    Manito, Nicolas
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [35] Efficacy and safety of sacubitril-valsartan in heart failure with reduced ejection fraction in end-stage renal patients
    Rascon Sabido, R. Rafael
    Rodriguez Cesar, Santos
    Escobar Gerardo, Baca
    Padron Lucio, San Juan
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 193 - 193
  • [36] Efficacy of Sacubitril-Valsartan on Survival and Cardiac Remodeling in Hypotensive Heart Failure With Reduced Ejection Fraction: A Multicenter Study
    Hsu, Chien -Yi
    Chung, Fa -Po
    Chao, Chieh-Ju
    Chen, Ying-Ju
    Wu, Cho -Kai
    Wu, Yen -Wen
    Huang, Jin -Long
    Chu, Pao-Hsien
    Hou, Charles Jia-Yin
    Chang, Hung-Yu
    Hung, Chung-Lieh
    MAYO CLINIC PROCEEDINGS, 2024, 99 (06) : 940 - 952
  • [37] Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction
    Gaziano, Thomas A.
    Fonarow, Gregg C.
    Velazquez, Eric J.
    Morrow, David A.
    Braunwald, Eugene
    Solomon, Scott D.
    JAMA CARDIOLOGY, 2020, 5 (11) : 1236 - 1244
  • [38] Safety and Efficacy of Sacubitril-Valsartan Initiation During and After Acute Decompensated Heart Failure with Reduced Ejection Fraction
    Tan, C. T.
    Koh, K. T.
    Said, A.
    Onn, Y. Y.
    Ho, K. H.
    Shu, F.
    Khiew, N. Z.
    Cham, Y. L.
    Fong, A. Y. Y.
    Ong, T. K.
    Amin, N. H. Mohd
    Eng, S. Y.
    Lee, Z. Y.
    Madzlan, N.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 297 : 4 - 4
  • [39] Effects of sacubitril-valsartan on clinical, echocardiographic and polygraphic parameters in patients affected by heart failure with reduced ejection fraction and sleep apnea
    Armentaro, G.
    Pelaia, C.
    Volpentesta, M.
    Mancuso, L.
    Cassano, V.
    Severini, G.
    Pastura, C. A.
    Francica, M.
    Barbara, K.
    Miceli, S.
    Maio, R.
    Caroleo, B.
    Perticone, M.
    Sesti, G.
    Sciacqua, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 836 - 836
  • [40] Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting
    Nordberg Backelin, Charlotte
    Fu, Michael
    Ljungman, Charlotta
    ESC HEART FAILURE, 2020, 7 (03): : 1049 - 1055